Obesity White Papers & Case Studies

  1. Streamlining The Clinical Trial Workflow From Protocol Design To Regulatory Submission 1/27/2026

    Learn how to create a direct line from clinical planning and protocol design to clinical trial disclosure to optimize efficiency across the entire trial lifecycle.

  2. Open-Label Study Assessing Relative And Absolute Bioavailability 1/26/2026

    Consistent absorption across different formulations and dietary conditions ensures stable therapeutic exposure. This flexibility simplifies patient dosing schedules and supports manufacturing transitions.

  3. Improving The eCOA Experience 1/25/2026

    Discover how template-driven builds and reuse can slash eCOA timelines by 50% while solving the licensing and translation hurdles that delay First Patient In.

  4. Serbia: Europe's Emerging Clinical Trial Powerhouse 1/22/2026

    Discover why Serbia is becoming a top strategic choice for sponsors, including details of the country's strengths in key therapeutic areas, streamlined processes, and operational advantages.

  5. PULSE: Empowering Every Phase of Your Clinical Journey 1/22/2026

    A flexible RTSM platform improves study startup, real‑time design updates, oversight, and global supply management, enabling faster execution, clearer visibility, and streamlined trial operations.

  6. Changing The Clinical Feasibility Game With AI 1/22/2026

    AI is only as good as the data it’s built upon. Our customized AI platforms are constructed on a foundation of trustworthy, carefully curated data to produce detailed, expert-driven responses.

  7. Advancing Neuromuscular Research with Digital Endpoints 1/20/2026

    Explore cutting-edge digital measures that capture peak mobility and activity in real-world settings, offering meaningful insights into disease progression in neuromuscular disorders.

  8. USP General Chapter 382: Health Inspired, Quality Driven 1/20/2026

    A new chapter outlines system‑level functional testing for elastomeric components used in parenteral packaging, emphasizing integrity, usability, and lifecycle compliance requirements across diverse delivery systems.

  9. What the FDA Looks For In Global Development Programs Today 1/16/2026

    Mastering the complexities of multi-regional clinical trials requires aligning global data with evolving regulatory expectations to ensure treatment consistency and successful drug approval.

  10. Central Nervous System Drug Development 1/16/2026

    CNS drug development faces unique hurdles — from high placebo response to complex protocols and recruitment challenges. Discover strategies to streamline trials, optimize planning, and accelerate delivery of innovative therapies for patients with critical unmet needs.